Sotera Health Co 8-K

What Happened Sotera Health Company (SHC) filed an 8-K (Item 5.02) reporting that Constantine S. Mihas notified the board on March 12, 2026 that he would resign as a Class I director, effective March 16, 2026, after a reduction in the number of directors certain stockholders may designate. The Board appointed Kenneth D. Krause as a Class I director, also effective March 16, 2026. Mr. Mihas’ resignation was not due to any disagreement with the Company. Mr. Krause will join the Audit Committee and the Litigation Committee.

Key Details

• Mihas notified the board on March 12, 2026; resignation effective March 16, 2026.
• Board appointed Kenneth D. Krause on March 15, 2026; appointment effective March 16, 2026.
• Krause is Executive VP & CFO of Rollins, Inc. since Sept 2022 (role expanded in 2024); previously SVP/CFO/CSO/Treasurer of MSA Safety (Dec 2015–Sept 2022).
• Krause is deemed independent under Nasdaq Rule 5605(a)(2), will enter the Company’s standard director indemnification agreement, and will receive non-employee director compensation (annual cash retainer and restricted stock units) per the Company’s 2025 proxy. No reportable related-party transactions were disclosed.

Why It Matters This filing documents a board composition change driven by a reduction in stockholder-designated directors, not by operational disagreement. For investors, the appointment of an experienced finance executive with CFO and audit experience (Krause) may strengthen financial oversight through his roles on the Audit and Litigation Committees. The company confirms independence, standard director compensation, and indemnification, and disclosed no related-party transactions tied to the appointment.